<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gasca-Capote C</submitter><funding>Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía</funding><funding>Instituto de Salud Carlos III</funding><funding>NIDDK NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>Junta de Andalucía</funding><funding>Gilead Fellowships</funding><pagination>e174215</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11014653</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>134(8)</volume><pubmed_abstract>BACKGROUNDPersistent controllers (PCs) maintain antiretroviral-free HIV-1 control indefinitely over time, while transient controllers (TCs) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir in terms of these phenotypes in order to identify the factors that lead to HIV progression and to open new avenues toward an HIV cure.METHODSThe characterization of HIV-1 reservoir from peripheral blood mononuclear cells was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-Seq; MIP-Seq).RESULTSPCs and TCs, before losing virological control, presented significantly lower total, intact, and defective proviruses compared with those of participants on antiretroviral</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.</pubmed_title><pmcid>PMC11014653</pmcid><funding_grant_id>R33 DA047034</funding_grant_id><funding_grant_id>R01 AI130005</funding_grant_id><funding_grant_id>U01 AI135940</funding_grant_id><funding_grant_id>U01 AI117841</funding_grant_id><funding_grant_id>R01 AI176579</funding_grant_id><funding_grant_id>UM1 AI164570</funding_grant_id><funding_grant_id>R01 DK120387</funding_grant_id><funding_grant_id>R01 MH134823</funding_grant_id><funding_grant_id>UM1 AI164560</funding_grant_id><funding_grant_id>R61 DA047034</funding_grant_id><funding_grant_id>R37 AI155171</funding_grant_id><funding_grant_id>GLD22/00147</funding_grant_id><funding_grant_id>R01 HL134539</funding_grant_id><funding_grant_id>UM1 AI164566</funding_grant_id><funding_grant_id>R21 AI116228</funding_grant_id><funding_grant_id>UM1 AI164562</funding_grant_id><funding_grant_id>US-75 1380938</funding_grant_id><funding_grant_id>R01 AI078799</funding_grant_id><funding_grant_id>R33 AI116228</funding_grant_id><funding_grant_id>R01 AI152979</funding_grant_id><funding_grant_id>FI17/00186,FI19/00083,MV20/00057,PI18/01532,PI19/01127,PI22/01796</funding_grant_id><funding_grant_id>PI20/1276</funding_grant_id><funding_grant_id>K24 AI155233</funding_grant_id><pubmed_authors>Peraire J</pubmed_authors><pubmed_authors>Rivero-Juarez A</pubmed_authors><pubmed_authors>Rafii-El-Idrissi Benhnia M</pubmed_authors><pubmed_authors>Gallego I</pubmed_authors><pubmed_authors>Espinosa N</pubmed_authors><pubmed_authors>Yu XG</pubmed_authors><pubmed_authors>Camacho-Sojo MI</pubmed_authors><pubmed_authors>Palacios R</pubmed_authors><pubmed_authors>Santos J</pubmed_authors><pubmed_authors>Rivero A</pubmed_authors><pubmed_authors>Lopez-Ruz MA</pubmed_authors><pubmed_authors>Gao C</pubmed_authors><pubmed_authors>Olalla J</pubmed_authors><pubmed_authors>Bachiller S</pubmed_authors><pubmed_authors>Hidalgo-Tenorio C</pubmed_authors><pubmed_authors>Rull A</pubmed_authors><pubmed_authors>Perreau M</pubmed_authors><pubmed_authors>Munoz-Medina L</pubmed_authors><pubmed_authors>Mastrangelo A</pubmed_authors><pubmed_authors>Lopez-Cortes LF</pubmed_authors><pubmed_authors>Lopez-Cortes LE</pubmed_authors><pubmed_authors>Cavassini M</pubmed_authors><pubmed_authors>Gasca-Capote C</pubmed_authors><pubmed_authors>Vitalle J</pubmed_authors><pubmed_authors>Vilades C</pubmed_authors><pubmed_authors>Perez-Gomez A</pubmed_authors><pubmed_authors>Gladkov G</pubmed_authors><pubmed_authors>Lian X</pubmed_authors><pubmed_authors>Collado-Romacho AR</pubmed_authors><pubmed_authors>Frias M</pubmed_authors><pubmed_authors>Ruiz-Mateos E</pubmed_authors><pubmed_authors>Ruiz-Sancho A</pubmed_authors><pubmed_authors>Vidal F</pubmed_authors><pubmed_authors>Roseto IC</pubmed_authors><pubmed_authors>Jimenez-Leon MR</pubmed_authors><pubmed_authors>Gomez-Ayerbe C</pubmed_authors><pubmed_authors>Lichterfeld M</pubmed_authors><pubmed_authors>Ostos FJ</pubmed_authors><pubmed_authors>Roca-Oporto C</pubmed_authors></additional><is_claimable>false</is_claimable><name>The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.</name><description>BACKGROUNDPersistent controllers (PCs) maintain antiretroviral-free HIV-1 control indefinitely over time, while transient controllers (TCs) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir in terms of these phenotypes in order to identify the factors that lead to HIV progression and to open new avenues toward an HIV cure.METHODSThe characterization of HIV-1 reservoir from peripheral blood mononuclear cells was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-Seq; MIP-Seq).RESULTSPCs and TCs, before losing virological control, presented significantly lower total, intact, and defective proviruses compared with those of participants on antiretroviral</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-04T05:30:08.934Z</modification><creation>2025-04-19T20:29:30.216Z</creation></dates><accession>S-EPMC11014653</accession><cross_references><pubmed>38376918</pubmed><doi>10.1172/JCI174215</doi></cross_references></HashMap>